Why Celldex Therapeutics Is Getting Crushed
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study......»»
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug......»»
Is Celldex Therapeutics, Inc. (CLDX) A Good Stock To Buy?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Amo.....»»
Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease......»»
Celldex Provides Corporate Update and Reports Third Quarter 2019 Results
HAMPTON, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2019. "Celldex achieved a significant milestone last week.....»»
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q2 2019 Results - Earnings Call Transcript
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q2 2019 Results - Earnings Call Transcript.....»»
Why Anika Therapeutics Stock Crushed It Today
What happe.....»»
Meditor Group Ltd Buys ProShares UltraPro Short QQQ, Sells Celldex Therapeutics Inc
Related Stocks: SQQQ, CLDX,.....»»
Wall Street Sees 3 Falling Knives Rebounding Within 52 Weeks
Celldex Therapeutics tops the listRelated Stocks: CLDX, ARPO, DWSN,.....»»
Celldex Therapeutics Continues to Stretch Out Its Cash and Advance Its Pipeline
The clinical-stage biotech effectively conserved cash in the first quarter, thanks to cost cuts following last year's pipeline setback with experimental cancer drug glemba......»»
Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?
Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease......»»
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call Transcript
Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2018 Results - Earnings Call Transcript.....»»
MGIC, Juniper Networks Slide into Wednesday’s 52-Week Low Club
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday......»»
Celldex"s Phase II Breast Cancer Study Fails, Shares Plunge
Celldex Therapeutics' (CLDX) glembatumumab vedotin fails to meet primary endpoint in phase IIb METRIC study in metastat.....»»
Celldex, Acacia Plummet into Monday’s 52-Week Low Club
Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday......»»
Celldex"s stock plummets toward record low after failed drug study
Shares of Celldex Therapeutics Inc. plummeted 40% in premarket trade Monday toward a record low, after the drug.....»»
What"s in Store for Celldex (CLDX) This Earnings Season?
With no approved product in Celldex Therapeutics' (CLDX) portfolio, investor focus is on i.....»»
Why Melinta Therapeutics Shares Are Getting Crushed
Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering......»»
Celldex Therapeutics Salvage Value
Celldex Therapeutics Salvage Value.....»»
Why Summit Therapeutics Was Crushed
Summit Therapeutics is another biopharma company that is paying the price on Wednesday......»»